Technology | Ultrasound Imaging | November 19, 2015

Philips Initiates U.S. Launch of Lumify Smart Device Ultrasound

Smart device solution designed to make ultrasound more accessible on demand

Philips, Lumify, smart device ultrasound, U.S. introduction

Image courtesy of Philips

Philips, Lumify ultrasound and transducers, RSNA 2015

Image courtesy of Philips

November 19, 2015 — Philips announced that Lumify, a smart device ultrasound solution, is available for purchase by licensed healthcare providers or organizations in the United States. Lumify is offered as part of a novel subscription model unique to the industry, according to Philips. From the company’s online portal, users will be able to order transducers, manage flexible subscriptions and access Philips’ support, training and IT services through the new offering. Philips’ new ultrasound digital health approach connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care and reduce costs.

Since debuting the smart device ultrasound concept in 2014, Philips has enhanced the solution for more clinical uses including acute care and office practice. As a comprehensive solution, Lumify extends the benefits of ultrasound to more places by leveraging cloud-enabled and tablet technology, and bringing connectivity, flexibility and mobility into the hands of more healthcare providers. 

Available with a monthly subscription starting at an introductory price of $199, Lumify allows institutions to scale their ultrasound solution to meet their needs and environment without having to purchase imaging equipment. The subscription includes a transducer, app, access to the online portal, warranty and Philips’ support.

Designed to help make ultrasound more accessible, Lumify operates on user-supplied compatible Android smart devices equipped with Internet and email functionality. To use Lumify, users download The Lumify App from Google Play, connect their Philips transducer to their compatible smart device via USB and launch the app to begin scanning. 

The Philips transducers available as part of the subscription support Lumify’s use in acute and emergency care, internal medicine, musculoskeletal (e.g., orthopedics, sports medicine and podiatry) urgent care and office practice. Philips’ advanced transducer technology, paired with cloud-enabled and tablet technology, helps users make fast, informed diagnoses through a variety of scan types. Lumify’s scanning app allows users to examine the gall bladder, abdomen and lungs, in addition to having OB-GYN, vascular, superficial, musculoskeletal and soft tissue functionality. 

"Lumify has the potential to provide on-demand, point-of-care diagnostics in a more connected environment," said Bret Nelson, M.D., associate professor of Emergency Medicine at Mount Sinai Hospital in New York. "We have been using the Philips Smart Device Ultrasound with our medical students. Leveraging a familiar device with portable diagnostic testing makes learning ultrasound easier for new users and more convenient for experienced imagers. I think that convenience and availability will increase the utility of this technology, improving patient care and efficiency.”

Lumify also uses cloud-enabled technology to connect with picture archiving and communication systems (PACS), shared networks and system directories. Additionally, data will be accessible on the Philips HealthSuite Digital Platform, an open and secure, cloud-based IT infrastructure, allowing clinicians and health systems access to data and analytics to help improve patient care. 

Lumify is a solution that will grow with its users, with plans for regular software updates and additional transducers, services and apps being released at regular intervals.

For more information: www.philips.com

Related Content

FDA Clears GE's Deep Learning Image Reconstruction Engine
Technology | Computed Tomography (CT) | April 19, 2019
GE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) of its Deep Learning Image...
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
Ebit and DiA Imaging Analysis Partner on AI-based Cardiac Ultrasound Analysis
News | Cardiovascular Ultrasound | April 16, 2019
DiA Imaging Analysis has partnered with the Italian healthcare IT company Ebit (Esaote Group), to offer DiA’s LVivo...
compressed breast during mammography.
360 Photos | 360 View Photos | April 16, 2019
A 360 view of a simulated breast compression for a...
Radiology Publishes Roadmap for AI in Medical Imaging
News | Artificial Intelligence | April 16, 2019
In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future...
Cambridge University Hospitals NHS Foundation Trust Implements Change Healthcare Enterprise Imaging
News | Enterprise Imaging | April 15, 2019
Change Healthcare successfully implemented its Radiology PACS (picture archiving and communication system), Image...
360 Photos | 360 View Photos | April 12, 2019
This 360 degree view shows staff at the ...
At RSNA 2018, Stratasys showed how 3-D printed models can help plan surgeries and assist in making complex diagnoses.

At RSNA 2018, Stratasys showed how 3-D printed models can help plan surgeries and assist in making complex diagnoses.

Feature | Enterprise Imaging | April 11, 2019 | By Jeff Zagoudis
The central premise behind en...
Photo courtesy of US Electronics

Photo courtesy of US Electronics

Feature | Flat Panel Displays | April 11, 2019 | By Melinda Taschetta-Millane
The flat panel display market shows signs of maturing, however many new applications are available that can help to s
Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Feature | Contrast Media Injectors | April 11, 2019 | By Jeff Zagoudis
One of the most controversial issues in radiology in recent years has been the use of...